These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 24522060)

  • 21. Serenoa repens for benign prostatic hyperplasia.
    Wilt T; Ishani A; Mac Donald R
    Cochrane Database Syst Rev; 2002; (3):CD001423. PubMed ID: 12137626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Saw palmetto for the treatment of men with lower urinary tract symptoms.
    Gerber GS
    J Urol; 2000 May; 163(5):1408-12. PubMed ID: 10751846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coagulopathy induced by saw palmetto: a case report.
    Villanueva S; González J
    Bol Asoc Med P R; 2009; 101(3):48-50. PubMed ID: 20120986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence-based systematic review of saw palmetto by the Natural Standard Research Collaboration.
    Ulbricht C; Basch E; Bent S; Boon H; Corrado M; Foppa I; Hashmi S; Hammerness P; Kingsbury E; Smith M; Szapary P; Vora M; Weissner W
    J Soc Integr Oncol; 2006; 4(4):170-86. PubMed ID: 17022925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A detailed safety assessment of a saw palmetto extract.
    Avins AL; Bent S; Staccone S; Badua E; Padula A; Goldberg H; Neuhaus J; Hudes E; Shinohara K; Kane C
    Complement Ther Med; 2008 Jun; 16(3):147-54. PubMed ID: 18534327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serenoa repens, selenium and lycopene to manage lower urinary tract symptoms suggestive for benign prostatic hyperplasia.
    Russo A; Capogrosso P; La Croce G; Ventimiglia E; Boeri L; Briganti A; Damiano R; Montorsi F; Salonia A
    Expert Opin Drug Saf; 2016 Dec; 15(12):1661-1670. PubMed ID: 27232207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Saw palmetto for benign prostatic hyperplasia.
    Dimitrakov JD
    N Engl J Med; 2006 May; 354(18):1950-1; author reply 1950-1. PubMed ID: 16673527
    [No Abstract]   [Full Text] [Related]  

  • 28. [Extract of Serenoa repens in the treatment of benign prostatic hyperplasia and lower urinary tract symptoms].
    Amdii RE; Al' Shukri AS
    Urologiia; 2018 May; (2):114-120. PubMed ID: 29901305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Extracts Serenoa repens in the treatment of prostatic adenoma and chronic abacterial prostatitis: results of short-term (3-month courses) therapy].
    Aliaev IuG; Vinarov AZ; Lokshin KL; Spivak LG
    Urologiia; 2007; (2):80-2. PubMed ID: 17578203
    [No Abstract]   [Full Text] [Related]  

  • 30. [The results of the 10-year study of efficacy and safety of Serenoa repens extract in patients at risk of progression of benign prostatic hyperplasia].
    Aliaev IuG; Vinarov AZ; Demidko IuL; Spivak LG
    Urologiia; 2013; (4):32-6. PubMed ID: 24159762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What do I tell patients about saw palmetto for benign prostatic hyperplasia?
    Kane CJ; Raheem OA; Bent S; Avins AL
    Urol Clin North Am; 2011 Aug; 38(3):261-77. PubMed ID: 21798388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatotoxicity potential of saw palmetto (Serenoa repens) in rats.
    Singh YN; Devkota AK; Sneeden DC; Singh KK; Halaweish F
    Phytomedicine; 2007 Feb; 14(2-3):204-8. PubMed ID: 16854576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Saw palmetto and lower urinary tract symptoms: what is the latest evidence?
    Avins AL; Bent S
    Curr Urol Rep; 2006 Jul; 7(4):260-5. PubMed ID: 16930496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A possible case of saw palmetto-induced pancreatitis.
    Wargo KA; Allman E; Ibrahim F
    South Med J; 2010 Jul; 103(7):683-5. PubMed ID: 20531057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Saw palmetto for benign prostatic hyperplasia.
    Casner PR
    N Engl J Med; 2006 May; 354(18):1950-1; author reply 1950-1. PubMed ID: 16672709
    [No Abstract]   [Full Text] [Related]  

  • 36. Anti-inflammatory properties of Lipidosterolic extract of Serenoa repens (Permixon®) in a mouse model of prostate hyperplasia.
    Bernichtein S; Pigat N; Camparo P; Latil A; Viltard M; Friedlander G; Goffin V
    Prostate; 2015 May; 75(7):706-22. PubMed ID: 25683150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Saw palmetto-induced pancreatitis.
    Jibrin I; Erinle A; Saidi A; Aliyu ZY
    South Med J; 2006 Jun; 99(6):611-2. PubMed ID: 16800417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Saw palmetto for benign prostatic hyperplasia.
    Bent S; Kane C; Shinohara K; Neuhaus J; Hudes ES; Goldberg H; Avins AL
    N Engl J Med; 2006 Feb; 354(6):557-66. PubMed ID: 16467543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extracts from fruits of saw palmetto (Sabal serrulata) and roots of stinging nettle (Urtica dioica): viable alternatives in the medical treatment of benign prostatic hyperplasia and associated lower urinary tracts symptoms.
    Koch E
    Planta Med; 2001 Aug; 67(6):489-500. PubMed ID: 11509966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological characterization and chemical fractionation of a liposterolic extract of saw palmetto (Serenoa repens): effects on rat prostate contractility.
    Chua T; Eise NT; Simpson JS; Ventura S
    J Ethnopharmacol; 2014 Mar; 152(2):283-91. PubMed ID: 24463033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.